基于中医传承计算平台的感染后咳嗽组方规律分析

doi:10.20047/j.issn1673-7210.2023.12.29

Abstract
Figure/Table
References (32)
Related Citation (15)

Download: PDF (3096 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the compatibility rules and formulation ideas of traditional Chinese medicine for post- infectious cough and to guide the clinical medication effectively. Methods Literature on the treatment of post-infectious cough by traditional Chinese medicine was retrieved from CNKI, VIP, and Wanfang Data from January 1997 to September 2021, and the database was established. The Traditional Chinese Medicine Inheritance Computing Platform V3.0 was used to carry out statistics of drug frequency, efficacy, nature and flavour, channel tropism and correlation analysis among drugs, and the core drug combination was obtained by k-means clustering analysis. Results A total of 188 prescriptions involving 162 kinds of traditional Chinese medicine were included, and 30 kinds of high-frequency drugs were screened out. The efficacy of 162 traditional Chinese medicine mainly includes dissipating phlegm, relieving cough, relieving dyspnea, relieving superficies, and tonifying deficiency classes. The medicinal natures were mainly warm, cold, and plain, and the medicinal flavours were mainly bitter, pungent, and sweet, and mainly attributed to the lung, spleen, stomach, heart, and liver channels. Through association rule analysis, 24 commonly used drug combinations and 28 groups of associated drugs were obtained. As a whole, the drug combination with “Glycyrrhizae Radix Et Rhizoma-Platycodonis Radix-Asteris Radix Et Rhizoma-Armeniacae Semen Amarum-Schizonepetae Herba-Stemonae Radix-Cynanchi Stauntonii Rhizoma Et Radix- Ephedrae Herba-Citri Reticulatae Pericarpium” as the core. Five core drug groups were obtained based on cluster analysis. Conclusion The traditional Chinese medicine prescriptions for post-infectious cough is characterized by dissipating phlegm, relieving cough, relieving dyspnea, relieving superficies, and tonifying deficiency, combining warm and cold, taking warm medicine as the key, and focusing on the core treatment features of lung qi, which provides theoretical basis for further exploring the clinical medication law of post-infectious cough and modern pharmacological research.

Key words： Post-infectious cough Traditional Chinese Medicine Inheritance Computer System Data mining Prescriptions rules

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SHI Weihong1 LYU Jun2 DOU Danbo1 YU Xiaoping1 SHEN Ruobing1

Cite this article:

SHI Weihong1 LYU Jun2 DOU Danbo1 YU Xiaoping1 SHEN Ruobing1. Analysis on the rules of post-infectious cough prescriptions based on Traditional Chinese Medicine Inheritance Computing Platform[J]. 中国医药导报, 2023, 20(12): 127-132.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.12.29 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I12/127

[1] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南（2015）[J].中华结核和呼吸杂志，2016，39（5）：323- 354.
[2] 胡诣璋，赵俊，崔瑷.感染后咳嗽发病机制及治疗进展[J].临床药物治疗杂志，2016，14（1）：11-16.
[3] 孙放，张纾难，王珏云，等.感染后咳嗽的中医病因病机及治疗[J].中华中医药杂志，2020，35（4）：1891-1893.
[4] 王晶.中医药治疗呼吸道病毒感染后咳嗽的疗效观察[J].临床医药文献杂志，2017，4（77）：15093-15094.
[5] 咳嗽的诊断依据、证候分类、疗效评定——中华人民共和国中医药行业标准《中医内科病证诊断疗效标准》（ZY/T001.1-94）[J].实用中医内科杂志，2020，34（6）：129.
[6] 国家药典委员会.中华人民共和国药典[S].一部.北京：中国医药出版社，2015.
[7] 戴红红，朱佳.朱佳教授治疗感染后咳嗽经验[J].四川中医，2018，36（4）：21-23.
[8] 刘完素.河间六书[M].张克敏，宋志萍，刘雅玲主编.山西科技出版社，2010.
[9] 吴普.神农本草经[M].孙星衍，孙冯翼撰.南宁：广西科学技术出版社，2016.
[10] 赵阳，周贤梅，何海浪，等.祛风润肺法治疗感染后咳嗽体会[J].山西中医，2017，33（5）：46.
[11] 朱满刚，钟悦嘉，许月球，等.李俊教授从风、痰、虚论治感染后咳嗽的经验[J].四川中医，2017，35（5）：19-21.
[12] 王开金，李娟，邱菊，等.止嗽散联合枸地氯雷他定对VPIC患者BALF细胞学、支气管上皮及炎症因子的影响[J].中国微生态学杂志，2018，30（7）：798-801.
[13] 黄亚若，隆红艳.隆红艳教授运用“祛风化痰”法治疗小儿风痰夹热证慢性咳嗽[J].亚太传统医药，2021，17（2）：126-128.
[14] 郭山逸.余小萍教授应用虫类药物治疗咳嗽变异性哮喘临床经验[J].河北中医，2019，41（2）：168-171.
[15] 权浩浩，张晓凤，高凯，等.基于网络药理学的僵蚕主要药效作用研究[J].西部中医药，2021，34（3）：92-99.
[16] Liu H，Fan X，Wang N，et al. Exacerbating effects of PM2.5 in OVA- sensitized and challenged mice and the expression of TRPA1 and TRPV1 proteins in lungs [J]. J Asthma，2017，54（8）：807-817.
[17] Wang P，Liu H，Fan X，et al. Effect of San'ao decoction on aggravated asthma mice model induced by PM2.5 and TRPA1/TRPV1 expressions [J]. J Ethnopharmacol，2019，236：82-90.
[18] 朱蕴菡.岭南中药化橘红研究进展[J].亚太传统医药，2016，12（24）：62-63.
[19] 曹贵兵.二陈汤合三子养亲汤加减治疗慢性阻塞性肺疾病痰湿壅肺证对胸肺顺应性及气体交换参数的影响[J].中国当代医药，2022，29（29）：127-131.
[20] 郭郡.加味二陈汤联合西药治疗老年社区获得性肺炎（痰湿阻肺证）的临床效果[J].中国医药科学，2021，11（3）：106-108.
[21] 胡晓怡，禹云梅.止嗽散合二陈汤加减治疗风寒犯肺型外感咳嗽临床观察[J].中西医结合研究，2021，13（5）：311-313.
[22] 夏婷婷.雾霾伤肺的证候特征及中医药防治的实验研究[D].武汉：湖北中医药大学，2017.
[23] 郑永艳，周园，周联，等.小青龙汤抗过敏作用及其机制研究[J].时珍国医国药，2017，28（5）：1052-1055．
[24] 韩东卫，杨琴琴，王利芳，等.基于整合药理学及分子对接技术探讨小青龙汤治疗慢性阻塞性肺疾病急性加重期的分子机制[J].中国医药导报，2022，19（10）：20-24.
[25] 吴兴树，苏智祥.小青龙汤加减联合西医常规对哮喘伴慢性阻塞性肺疾病支气管痉挛患者的治疗作用[J].西部中医药，2022，35（9）：111-114.
[26] 张平安，高娜，陈明哲，等.基于网络药理学探讨小青龙汤治疗慢性阻塞性肺疾病的作用机制[J].世界中医药，2021，16（24）：3585-3590，3595.
[27] 丁建中，张六通，龚权，等.桑杏汤对温燥小鼠气管纤毛运动与呼吸道液及免疫功能的影响[J].中药药理与临床，2006，22（5）：4-5.
[28] 刘倩倩.加减桑杏汤治疗燥邪犯肺证咳嗽变异性哮喘有效性和安全性的随机对照临床研究[D].乌鲁木齐：新疆医科大学，2020.
[29] 刘永萍，蒋建纲.百合固金汤治疗慢性阻塞性肺疾病稳定期50例[J].中国实验方剂学杂志，2013，19（10）：33.
[30] 张敏，许成辰，徐婷贞，等.基于Nrf2/Keap1/p62信号通路探讨百合固金汤对LPS诱导的小鼠急性肺损伤的保护作用[J].中国实验方剂学杂志，2019（15）：77-82.
[31] 付小刚，张永平，郑云平，等.百合固金汤治疗慢性阻塞性肺疾病稳定期患者的临床效果[J].医疗装备，2020， 33（19）：67，70.
[32] 朱娟.百合固金汤+孟鲁司特钠对咳嗽变异性哮喘患者肺功能及复发率的影响[J].内蒙古中医药，2020，39（5）：74-75.